PHARMACIE DE LA CIGOGNE : revenue, balance sheet and financial ratios

PHARMACIE DE LA CIGOGNE is a French company founded 12 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in WITTELSHEIM (68310), this company of category PME shows in 2021 a revenue of 1.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DE LA CIGOGNE (SIREN 794653337)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C 1 857 954 € 1 747 218 € 1 714 345 € 1 709 169 € 1 760 547 € 1 762 495 €
Net income 87 302 € 78 362 € 97 645 € 74 741 € 57 287 € -9 662 € 21 156 € 71 814 € 66 784 € 68 528 €
EBITDA N/C N/C N/C N/C 85 884 € 7 178 € 34 934 € 108 282 € 109 932 € 114 419 €
Net margin N/C N/C N/C N/C 3.1% -0.6% 1.2% 4.2% 3.8% 3.9%

Revenue and income statement

Im Jahr 2025 erzielt PHARMACIE DE LA CIGOGNE ein positives Nettoergebnis von 87 k€. Entwicklung 2016-2025: 69 k€ -> 87 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

87 302 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 27%. Dieses niedrige Niveau spiegelt eine solide Finanzstruktur wider. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 71%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

27.159%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

71.214%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

82.0%

Solvency indicators evolution
PHARMACIE DE LA CIGOGNE

Sector positioning

Verschuldungsgrad
27.16 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Gut +9 pts over 3 years

Im Jahr 2025 liegt unter dem Median der Branche das verschuldungsgrad von PHARMACIE DE LA CIGOGNE (27.16). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Diese kontrollierte Position spiegelt umsichtiges Management wider.

Finanzielle Autonomie
71.21% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Gut

Im Jahr 2025 liegt über dem Median der Branche das finanzielle autonomie von PHARMACIE DE LA CIGOGNE (71.2%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Diese komfortable Position bietet eine nennenswerte Sicherheitsmarge.

Liquidity ratios

Die Liquiditätsquote beträgt 210.82. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

210.817

Liquidity indicators evolution
PHARMACIE DE LA CIGOGNE

Sector positioning

Liquiditätsquote
210.82 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Gut +39 pts over 3 years

Im Jahr 2025 liegt über dem Median der Branche das liquiditätsquote von PHARMACIE DE LA CIGOGNE (210.82). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Diese komfortable Position bietet eine nennenswerte Sicherheitsmarge.

Working capital requirement (WCR) and payment terms

Der Betriebskapitalbedarf (WCR) misst die zeitliche Lücke.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DE LA CIGOGNE

Positioning of PHARMACIE DE LA CIGOGNE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE DE LA CIGOGNE is estimated at 1 386 802 € (range 941 090€ - 2 176 084€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
941k€ 1386k€ 2176k€
1 386 802 € Range: 941 090€ - 2 176 084€
NAF 5 année 2025

Valuation method used

Net Income Multiple
87 302 € × 15.9x = 1 386 803 €
Range: 941 091€ - 2 176 084€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE LA CIGOGNE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DE LA CIGOGNE

What is the revenue of PHARMACIE DE LA CIGOGNE ?

The revenue of PHARMACIE DE LA CIGOGNE in 2021 is 1.9 M€.

Is PHARMACIE DE LA CIGOGNE profitable?

Yes, PHARMACIE DE LA CIGOGNE generated a net profit of 87 k€ in 2025.

Where is the headquarters of PHARMACIE DE LA CIGOGNE ?

The headquarters of PHARMACIE DE LA CIGOGNE is located in WITTELSHEIM (68310), in the department Haut-Rhin.

Where to find the tax return of PHARMACIE DE LA CIGOGNE ?

The tax return of PHARMACIE DE LA CIGOGNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE LA CIGOGNE operate?

PHARMACIE DE LA CIGOGNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.